drugset / Trial / NCT03208179

Summary

This study evaluates the efficacy and safety of monthly intermittent preventive treatment using dihydroartemisinin piperaquine (DP) alone or in combination with azithromycin (AZ) compared to sulphadoxine-pyrimethamine (SP) for the prevention of malaria in pregnant women in the second and third trimester.

Timeline

Start
2018-03-29
Primary completion
2020-03-15
Completion
2020-03-15

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule 500 mg
Subject Dihydroartemisinin-piperaquine Unknown 40 mg
Subject Dihydroartemisinin-piperaquine Unknown 320 mg
Comparator sulphadoxine-pyrimethamine Small molecule 75 mg
Comparator sulphadoxine-pyrimethamine Small molecule 1500 mg